Case of type 1 diabetes associated with less-dose nivolumab therapy in a melanoma patient

J Dermatol. 2017 May;44(5):605-606. doi: 10.1111/1346-8138.13486. Epub 2016 Jun 23.

Authors

Affiliations

¹ Department of Skin Oncology/Dermatology, Saitama Medical University International Medical Center, Saitama, Japan.
² Division of Traumatology and Emergency Acute Medicine, Saitama Medical University International Medical Center, Saitama, Japan.
³ Department of Endocrinology and Diabetes, Saitama Medical University, Saitama, Japan.

PMID: 27334247
DOI: 10.1111/1346-8138.13486

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Agents, Immunological / administration & dosage
Antineoplastic Agents, Immunological / adverse effects*
Diabetes Mellitus, Type 1 / chemically induced*
Disease Progression
Female
Humans
Melanoma / drug therapy*
Middle Aged
Nivolumab / administration & dosage
Nivolumab / adverse effects*
Vulvar Neoplasms / drug therapy*

Substances

Antineoplastic Agents, Immunological
Nivolumab